Body Area Network

Body Area Network (BAN) is a wireless network of sensors, devices, and communication nodes worn on, implanted within, or positioned in close proximity to the human body. Operating under the IEEE 802.15.6 standard ratified in 2012, BANs are designed to collect, relay, and transmit biometric and physiological data in real time. Originally conceived for medical monitoring, BAN technology has rapidly expanded into military, fitness, and — according to researchers such as Sabrina Wallace — covert population surveillance applications. The convergence of BAN infrastructure with Nanotechnology, graphene-based biosensors, and Internet of Bodies frameworks raises significant concerns about bodily autonomy and unsanctioned monitoring of human beings.

Diagram illustrating a Body Area Network (BAN), showing wireless sensor nodes positioned around and on the human body communicating with a central hub device.

What is a BAN?

A Body Area Network encompasses all networked devices operating within or immediately around the human body, typically within a range of two metres. Several closely related terms are used interchangeably or as subcategories:

• WBAN (Wireless Body Area Network) — the wireless implementation of a BAN, linking sensors without physical cabling. See Wireless Body Area Network.
• MBAN (Medical Body Area Network) — a subtype focused specifically on clinical patient monitoring, regulated in the United States under FCC spectrum allocations from 2012.
• BSN (Body Sensor Network) — a broader academic term emphasising the sensor-node mesh architecture on and within the body.

All subtypes share a common architecture built around two fundamental node types:

Body Central Unit (BCU)

The Body Central Unit (BCU) serves as the hub node of the network. It aggregates data from all peripheral sensors, manages communication scheduling, and handles uplink to external networks such as hospital servers, cloud systems, or — in military contexts — command infrastructure. The BCU typically takes the form of a smartphone, dedicated medical gateway device, or an embedded processing unit. In emerging intra-body network research, some investigators suggest that implanted nano-scale devices may perform BCU functions autonomously within the human body.

Body Sensor Unit (BSU)

Body Sensor Units (BSUs) are the peripheral sensor nodes distributed across the body. They measure parameters such as heart rate, blood oxygen, skin temperature, electrodermal activity, neural signals, and motion. BSUs transmit data either directly to the BCU or via a mesh relay through neighbouring nodes. In medical-grade deployments, BSUs are typically external wearable patches. However, nanotechnology research — including work on Smart Dust and Neural Dust — envisions BSU-equivalent devices at sub-millimetre scale operating internally.

Standards and Protocols

IEEE 802.15.6 is the primary international standard governing BAN communications, published by the Institute of Electrical and Electronics Engineers. It defines the physical (PHY) and medium access control (MAC) layers for short-range, low-power wireless communication on, in, and around the human body.

Physical Layer Options

• NB PHY (Narrowband Physical Layer) — operates across multiple frequency bands including the MICS Band (Medical Implant Communication Service, 402–405 MHz), the ISM Band (Industrial, Scientific, and Medical bands at 2.4 GHz), and other sub-GHz allocations. NB PHY is suited to low-data-rate continuous monitoring.
• UWB PHY (Ultra-Wideband Physical Layer) — provides higher data throughput and more precise localisation capability. UWB is increasingly relevant to military biosensing and positioning applications.
• HBC (Human Body Communication) — a distinct PHY mode that uses the human body itself as a conductive medium to transmit electrical signals between devices. Rather than radiating signals through the air, HBC routes data through skin and tissue. Researchers such as Sabrina Wallace have drawn particular attention to HBC as an underappreciated mechanism by which the body may function as a literal communication channel.

Networking Protocols

• 6LoWPAN (IPv6 over Low-Power Wireless Personal Area Networks) — enables BAN nodes to be addressed using standard IPv6, integrating body-worn sensors directly into the broader internet infrastructure. This is a foundational element of the Internet of Bodies concept.
• MICS Band regulation requires low transmission power, limiting range but reducing interference with other medical equipment.

Medical and Military Applications

Medical Applications

The stated primary purpose of BAN technology is patient health monitoring. Clinical deployments include:

• Continuous cardiac monitoring via wearable ECG patches transmitting to hospital systems
• Glucose monitoring for diabetic patients without finger-prick sampling
• Post-surgical remote observation, reducing hospital readmission rates
• Neurological monitoring, including EEG-based seizure detection systems
• Fall detection and mobility tracking for elderly patients

Remote health management programmes — in which patients are discharged from hospital but remain connected to clinical systems via BAN — have been promoted by national health services globally. These systems feed data into centralised health databases, raising questions about data ownership and secondary use.

Military Biosensing

Defence agencies, particularly DARPA, have invested substantially in BAN technology for battlefield applications:

• Continuous physiological monitoring of soldiers to detect fatigue, stress, and injury in real time
• Cognitive performance tracking, linking to Brain-Computer Interface research
• Covert biometric identification of personnel and tracking in contested environments
• Integration with exoskeleton and augmented reality systems requiring precise body-state data

The U.S. Department of Defense's interest in soldier-worn biosensor networks predates the civilian IEEE standard, with classified programmes reportedly developing implantable monitoring devices for special operations forces.

Surveillance and Control Concerns

FCC 2012 MBAN Spectrum Allocation

In 2012, the U.S. Federal Communications Commission (FCC) allocated the 2360–2400 MHz spectrum band specifically for Medical Body Area Networks. While framed as enabling better hospital patient monitoring, critics noted that this allocation — combined with the 6LoWPAN IPv6 addressing capability embedded in IEEE 802.15.6 — creates the infrastructure for body-level devices to be individually addressable nodes on the internet.

Sabrina Wallace, an independent researcher who has extensively documented BAN architecture in relation to Targeted Individuals, argues that this infrastructure was not designed solely for consenting medical patients. She contends that the same network topology is applicable to non-consensual monitoring of individuals via implanted or aerosolised nano-scale devices — connecting BAN architecture to the broader Biosurveillance and Internet of Bodies agendas.

Population Monitoring

The combination of Biosurveillance infrastructure, BAN standards, and widespread deployment of Smart Dust-class nano devices creates a theoretical framework for population-level biometric monitoring. Key concerns raised by researchers include:

• IPv6 addressing enabling unique identification of body-worn or in-body devices without individual consent
• Data aggregation linking physiological state to geolocation, enabling behaviour prediction
• Integration with 5G and 6G infrastructure providing ubiquitous uplink capacity from body-level sensors
• The potential for BAN nodes — whether wearable or injected via COVID Vaccines according to some researchers — to transmit without the host's knowledge

These concerns are not merely theoretical: the Internet of Bodies as described by the World Economic Forum explicitly envisions human bodies as nodes in a networked information ecosystem.

The Biofield and Body Area Networks

Conceptual illustration of the human bioelectric field surrounding the body

A dimension of BAN engineering that receives little attention in mainstream technical literature — but which is directly relevant to understanding how WBAN infrastructure interacts with living biology — is the role of the Biofield: the aggregate electromagnetic field produced by the body's own biological activity.

What Is the Biofield?

The Biofield is the measurable electromagnetic environment generated by the human body as a by-product of normal physiological processes. It is not a speculative construct; its constituent components are well-documented in clinical and research settings:

• The heart generates the body's strongest bioelectric signal, detectable by electrocardiography (ECG) and producing a magnetic field measurable by magnetocardiography (MCG) at distances of several metres.
• The brain generates continuous electrical oscillations — alpha, beta, theta, and gamma waves — detectable via electroencephalography (EEG) and magnetoencephalography (MEG).
• The Peripheral Nervous System produces coordinated bioelectric impulses along nerve fibre pathways throughout the body, constituting a distributed low-frequency electrical network running through every limb and organ system.
• Cellular ion exchange processes produce microvolt-level electrical gradients across tissue interfaces throughout the body.

Together, these sources create a complex, structured electromagnetic environment that permeates and surrounds the body. Biofield Physiology — the formal study of this field and its functional role in biological regulation — documents how the biofield is not merely a passive emission but actively participates in intercellular signalling and tissue coordination.

Biofield as EM Propagation Environment for HBC

Human Body Communication (HBC), the PHY mode defined within IEEE 802.15.6 that uses body tissue as a signal conduit rather than radiating signals through air, does not operate in a biologically neutral medium. It operates directly within the biofield environment.

The body's tissues — skin, muscle, blood, nerve — have well-characterised dielectric and conductive properties that vary with frequency. HBC exploits these properties to route electrical signals between devices worn on or embedded within the body. Critically, the frequency ranges used by HBC (typically DC to ~100 MHz in galvanic coupling mode, and sub-GHz in capacitive coupling mode) substantially overlap with the frequency spectrum of bioelectric activity generated by the nervous system and cardiac cycle.

This means that:

1. HBC signal propagation is shaped and modulated by the body's own bioelectric activity.
2. The existing biofield constitutes a pre-formed propagation environment that HBC engineering leverages — whether or not this is explicitly acknowledged in the standard's documentation.
3. Changes in physiological state (stress, cardiac rhythm, neural activation) alter the biofield's EM characteristics, which in turn affect HBC channel properties — a relationship that BAN engineering must model to achieve reliable communication.

From an engineering standpoint, the biofield is therefore an implicit infrastructure layer beneath the formal PHY layer specified in IEEE 802.15.6. It is the biological substrate upon which HBC communication is superimposed.

Frequency Overlap with IEEE 802.15.6 HBC Bands

The IEEE 802.15.6 standard's HBC physical layer defines two primary operating modes:

• Galvanic coupling HBC — injects differential electrical signals directly into body tissue, operating in the range of approximately 100 kHz to 100 MHz.
• Capacitive coupling HBC — uses the body as one plate of a capacitor, coupling to an external ground reference, and operates in similar sub-100 MHz ranges.

The bioelectric activity of the Peripheral Nervous System spans from sub-Hz (slow nerve potentials) through to several kHz (action potential frequencies). Cardiac signals occupy the DC–1 kHz range. Neural oscillations as measured by EEG span 0.5–100 Hz in conventional recording, with high-frequency oscillations extending into the kHz range.

While HBC carrier frequencies are typically higher than the dominant bioelectric frequencies, the biofield environment generates harmonics and intermodulation products that overlap with lower HBC sub-bands. More significantly, the tissue electrical properties that determine HBC channel characteristics — conductivity, permittivity, and their frequency dependence — are actively maintained and regulated by the body's own bioelectrical systems. The nervous system's electrochemical activity is not separable from the physical medium through which HBC signals travel.

Sabrina Wallace: The Biofield as an Unconsented Network Layer

Sabrina Wallace has been among the most prominent independent researchers to articulate the significance of the biofield within WBAN architecture in terms relevant to Targeted Individuals and covert surveillance. Her analysis, documented in part in the reference material ', extends the technical observation of biofield-HBC overlap into a broader argument about consent and exploitation.

Wallace's position can be summarised as follows:

• The biofield is not a passive background to WBAN operation — it is an active biological EM layer that WBAN and HBC infrastructure couples with in order to function.
• IEEE 802.15.6 was developed with full awareness of the body's bioelectric properties; the HBC PHY mode is explicitly designed to exploit tissue conductivity and the body's capacitive relationship with its environment.
• When WBAN devices are deployed without the knowledge of the individual — whether via aerosolised nano-scale particles, injected materials in COVID Vaccines, or other undisclosed delivery mechanisms — the coupling with the individual's biofield occurs without consent.
• The biofield therefore constitutes what Wallace describes as an implicit network layer: a biologically generated EM infrastructure that engineered systems can couple with, read from, and potentially write to — without the host individual being aware that their own body's electromagnetic properties are being utilised as a communication substrate.

Wallace further argues that the DARPA ElectRx programme — which explicitly targets the Peripheral Nervous System as a site for bioelectronic intervention — represents a deliberate convergence between biofield exploitation and networked biosensing. ElectRx, which sought to develop miniaturised devices capable of modulating peripheral nerve activity, effectively treats the peripheral nervous system as both a sensing target and a modifiable signal layer within a broader bioelectronic network.

DARPA ElectRx and Peripheral Nervous System Coupling

DARPA ElectRx (Electrical Prescriptions) was a DARPA programme that aimed to develop closed-loop, implantable bioelectronic devices capable of monitoring and modulating activity in the Peripheral Nervous System to treat inflammatory and psychiatric conditions. While its stated goals were therapeutic, the programme's technical architecture is directly relevant to BAN biofield coupling:

• ElectRx devices were designed to detect and interpret nerve signal patterns — effectively functioning as BSU-class BAN nodes interfaced directly with peripheral nerve tissue.
• The closed-loop feedback architecture (sense → process → stimulate) mirrors the BCU/BSU functional model of BAN operation.
• Operating at the bioelectric signal level of peripheral nerves, ElectRx devices operate within the same frequency environment as the biofield's nervous-system-generated EM activity.

According to researchers examining the convergence of DARPA bioelectronics and BAN infrastructure, programmes like ElectRx represent a formalisation of biofield exploitation as an engineering objective: the body's own electrical signalling pathways are treated as both the sensing medium and the intervention target for networked bioelectronic systems.

Diagram of the human peripheral nervous system showing nerve pathways throughout the body

Implications for Bodily Autonomy

The intersection of biofield science and BAN engineering raises fundamental questions that extend beyond technical architecture into the domain of Bodily Autonomy:

• If the body's biofield constitutes a natural EM environment that WBAN infrastructure couples with, does the deployment of such infrastructure — even at a distance — constitute an unauthorised interaction with a person's biological systems?
• The Peripheral Nervous System's role as both a biofield generator and an ElectRx-class intervention target suggests that bioelectronic systems can interact with the body's signalling architecture at the nerve level, potentially altering physiological and cognitive states, without the individual's awareness or consent.
• The IEEE 802.15.6 standard does not address biofield coupling or the ethical implications of HBC operating within the body's biological EM environment — a gap that critics argue reflects a deliberate omission rather than an oversight.

These concerns connect to the broader framework of covert bioelectronic surveillance and modulation discussed across this wiki under Biosurveillance, Targeted Individuals, Intra-Body Nano Network, and Brain-Computer Interface.

Body Network Nodes

Understanding BAN architecture requires clarity on how nodes are classified and how they communicate:

Node Roles

Node Type	Role	Typical Location
BCU (Body Central Unit)	Hub / gateway	Wrist, chest, or embedded
BSU (Body Sensor Unit)	Peripheral sensor	Limbs, torso, scalp, implanted
Relay Node	Mesh repeater	Between BCU and distant BSU

BSUs operate in either star topology (each BSU communicates directly to BCU) or mesh topology (BSUs relay through one another), the latter being more resilient and better suited to in-body nano-scale implementations where individual node power is severely constrained.

Power and Harvesting

A persistent challenge for implanted or nano-scale BAN nodes is power supply. Research directions include:

• RF energy harvesting — nodes scavenge power from ambient radio frequency fields, including 5G transmissions
• Piezoelectric harvesting — converting body movement into electrical energy
• Thermoelectric harvesting — exploiting body heat differentials

The feasibility of RF-powered nano-nodes operating within the body, drawing energy from ambient wireless infrastructure, is a recurring theme in both academic literature and the research of investigators such as Sabrina Wallace and Mik Andersen.

Relationship to Intra-Body Networks

BAN technology as defined by IEEE 802.15.6 describes devices at the wearable or surgically implanted scale. However, a growing body of research and investigation concerns a sub-scale extension of the same concept: the Intra-Body Nano Network.

This hypothetical (and, some argue, already-emerging) network would consist of nano-scale devices — potentially including Graphene-based biosensors, Smart Dust particles, or Neural Dust — distributed throughout body tissue and operating as BSU-equivalent nodes. These would communicate via HBC (body tissue conductance), near-field coupling, or terahertz-range wireless, aggregating data to a BCU gateway device or directly to external infrastructure.

Key related concepts:

• Graphene — due to its exceptional electrical conductivity and biocompatibility, graphene is proposed as a substrate for nano-scale BAN nodes
• Smart Dust — micro-scale wireless sensor nodes that could function as distributed BSUs
• Neural Dust — ultrasound-powered neural recording implants developed at UC Berkeley; a demonstrated BSU-class technology for in-body BAN deployment
• Intra-Body Nano Network — the theoretical framework describing how such nano-nodes would communicate and aggregate data within a living human body
• Brain-Computer Interface — advanced BAN deployments extend into direct neural interfacing
• Biofield — the body's aggregate electromagnetic field, constituting the biological EM environment within which intra-body nano-networks would operate
• Peripheral Nervous System — the distributed bioelectric network whose activity shapes the biofield propagation environment

The line between the documented IEEE 802.15.6 Body Area Network standard and speculative intra-body nano-networking is, according to researchers in this field, narrowing rapidly.

See Also

• Wireless Body Area Network
• IEEE 802.15.6
• Internet of Bodies
• Intra-Body Nano Network
• Biosurveillance
• Brain-Computer Interface
• Sabrina Wallace
• Smart Dust
• Neural Dust
• Graphene
• 5G
• 6G
• WBAN
• Nanotechnology
• Biofield
• Biofield Physiology
• Peripheral Nervous System
• DARPA ElectRx
• Human Body Communication

References

• IEEE Std 802.15.6-2012 — IEEE Standard for Local and Metropolitan Area Networks: Wireless Body Area Networks
• FCC Report and Order, ET Docket No. 08-59 (2012) — Medical Body Area Network spectrum allocation
• Movassaghi, S. et al. (2014). "Wireless Body Area Networks: A Survey." IEEE Communications Surveys & Tutorials
• Salayma, M. et al. (2017). "Wireless Body Area Network (WBAN)." IEEE Access
• Wallace, S. (2026). Biofield and Medical Body Area Network.
• DARPA ElectRx Programme Overview — Electrical Prescriptions (ElectRx): Targeted Peripheral Neuromodulation
• Oschman, J.L. (2000). Energy Medicine: The Scientific Basis. Churchill Livingstone.
• Rubik, B. et al. (2015). "Biofield Science and Healing: History, Terminology, and Concepts." Global Advances in Health and Medicine